JUL 22, 2019 3:35 PM PDT

New Diabetes Gene Revealed by Large Study of African Populations

WRITTEN BY: Carmen Leitch

While we all carry more or less the same genes, tiny differences in the sequences of those genes can have major ramifications. Genome-wide association studies (GWAS) help researchers identify the variations in gene sequences that have an impact on a trait, like a susceptibility to disease. Most GWAS that have been performed have focused on populations with European ancestry while ignoring others, and as such, there is a dearth of information when it comes to some groups, like Africans.  Geneticists are aware of the problem (discussed in the video below) and have been working for some time to expand what we know about the genetics of these underserved populations.

Image credit: Max Pixel

“Africa is the original cradle of all humanity, to which all humans can trace their genetic origin,” said study co-author Francis S. Collins, M.D., Ph.D., a senior investigator with the National Human Genome Research Institute (NHGRI) Medical Genomics and Metabolic Genetics Branch. “Thus, studying the genomes of Africans offers important opportunities to understand genetic variation across all human populations.”

A study recently published in Nature Communications by researchers at the National Institutes of Health and the University of Maryland, Baltimore (full disclosure: I am one of the study authors), is the largest type 2 diabetes (T2D) GWAS study done with a sub-Saharan African population. After assessing data from 5,231 people in Ghana, Nigeria, and Kenya, the team identified variations in several genes that are linked to diabetes. The report focused on one of those genes, called ZRANB3. While the researchers had learned that the gene is connected to diabetes, they want to know more about how.

“In the early days of large-scale genomic studies, we did not know the effect of genes we found through our statistical tests,” explained study first author Dr. Adebowale Adeyemo, NHGRI researcher. “But with the availability of new genomic tools, our next step was to ask: What does ZRANB3 do? How does it confer risk for T2D, and by what mechanisms does it act? That is the knowledge that will help the results become actionable for patients.”

The scientists studied the impact of the ZRANB3 gene in zebrafish. Since zebrafish are transparent, they can be observed throughout development. A transgenic model was used in this study, in which the beta cells in the zebrafish pancreas glow red. The beta cells produce insulin, which is a molecule that helps control the level of glucose in the blood. I created a ZRANB3 knockout in this model using the CRISPR/Cas9 gene-editing system that targeted the ZRANB3 zebrafish gene and we watched the effects.

Confocal microscopy revealed that when ZRANB3 was down-regulated in fish, it reduced the number of beta cells in their pancreas. These results were confirmed in mouse cells growing in culture.

While this study has revealed more about a genetic variation likely to be found in Africans, the variant might also be carried by people in other groups as well. It can also help us understand more about the genetics underlying a complex disorder like diabetes, which is more likely to arise in some people that carry certain genetic variations. We may also be able to one day predict who will probably develop certain diseases based on the genetic variations they have.

“The findings of this study further demonstrate why it is important to study all human populations. By doing so, we have the opportunity to make novel discoveries that will not only help the specific population but also people all around the globe,” said study senior author Dr. Charles Rotimi. “The biology then becomes generalizable, and that much more impactful.”

Learn more about GWAS from the video.

Sources: NHGRI, Nature Communications

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 19, 2020
Immunology
JAN 19, 2020
Overactive Immune Gene May Cause Schizophrenia
A windy road links excessive activity of the “C4” gene to the development of schizophrenia. Researchers begin to study C4 activity as part of n
JAN 20, 2020
Genetics & Genomics
JAN 20, 2020
Braveheart RNA Structure is Revealed For the First Time
Protein-coding genes only make up a small part of the genome. Much of the rest may contain long, non-coding RNA sequences.
FEB 02, 2020
Cancer
FEB 02, 2020
These cosmetics damage breast cells' DNA
A new approach to studying the effects of two common chemicals used in cosmetics and sunscreens found they can cause DNA damage in breast cells at surprisi
FEB 07, 2020
Genetics & Genomics
FEB 07, 2020
Mutations That Lead to Cancer May Occur Decades Before Diagnosis
As our cells age or divide, errors can accumulate in the genome they carry, which can lead to cancer, and a variety of environmental and genetic factors ca
MAR 29, 2020
Cancer
MAR 29, 2020
MicroRNA as a New Way to Test for Lung Cancer
The most common, and most deadly, cancer across the world is lung cancer. If caught early, lung cancer has quite a low mortality rate. MicroRNAs may prove to be the answer.
APR 04, 2020
Cannabis Sciences
APR 04, 2020
Only 50% Cannabis Genome Has Been Mapped
As more and more jurisdictions are decriminalizing cannabis usage, its popularity both for medicinal and recreational use is growing around the world. Desp
Loading Comments...